TransMedics Group, Inc.
- CIK: 0001756262
- EIN: 00-0000000
- Business address: 200 MINUTEMAN ROAD, ANDOVER, Massachusetts, 01810
Information
Mailing address
200 MINUTEMAN ROAD, ANDOVER, Massachusetts, 01810Phone
9785520900State location
MassachusettsState of incorporation
MassachusettsFiscal year end
December 31SIC
3845 - (CF Office: Office of Life Sciences) ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSFilings
N/A
About TransMedics Group, Inc.
TransMedics Group, Inc. (CIK: 0001756262) is an American company incorporated in the state of Massachusetts. Head office is located at 200 MINUTEMAN ROAD, ANDOVER, Massachusetts, 01810. Work in the industry 3845 - (CF Office: Office of Life Sciences) ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS. TransMedics Group, Inc. is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Ranganath Anil P. | 0001980144 | Jun-05-2023 | officer: See Remarks |
| Corcoran Nicholas | 0001964148 | Jan-23-2023 | officer: See Remarks |
| Godhani Rakesh P. | 0001876878 | Aug-04-2021 | officer: Chief Digital Officer |
| Lovell Stephanie | 0001772054 | Mar-22-2021 | director |
| RAINES MERILEE | 0001023869 | Jan-01-2021 | director |
| DAMME LAURA | 0001784433 | Aug-05-2019 | officer: VP, Clinical Affairs |
| UNITED THERAPEUTICS Corp | 0001082554 | May-01-2019 | 10 percent owner |
| ABRAMS CAPITAL, LLC | 0001112443 | May-01-2019 | 10 percent owner |
| ABRAMS CAPITAL MANAGEMENT, LLC | 0001165407 | May-01-2019 | 10 percent owner |
| TOBIN JAMES R | 0001190128 | May-01-2019 | director |
| AFEYAN NOUBAR | 0001222012 | May-01-2019 | 10 percent owner |
| KANIA EDWIN M JR | 0001255927 | May-01-2019 | director |
| Abrams David C | 0001292250 | May-01-2019 | 10 percent owner |
| Abrams Capital Partners II, L.P. | 0001292420 | May-01-2019 | 10 percent owner |
| Gilbert James | 0001312685 | May-01-2019 | director |
| ABRAMS CAPITAL MANAGEMENT, L.P. | 0001358706 | May-01-2019 | 10 percent owner |
| Khayal Tamer I | 0001430462 | May-01-2019 | officer: Chief Commercial Officer |
| Hassanein Waleed H | 0001430466 | May-01-2019 | director, officer: President & CEO |
| Flagship Ventures Fund IV, L.P. | 0001503559 | May-01-2019 | 10 percent owner |
| Flagship Ventures Fund IV General Partner LLC | 0001508051 | May-01-2019 | 10 percent owner |
| Flagship Ventures Fund 2007, L.P. | 0001508052 | May-01-2019 | 10 percent owner |
| Flagship Ventures 2007 General Partner LLC | 0001508053 | May-01-2019 | 10 percent owner |
| Riva Capital Partners III, L.P. | 0001525135 | May-01-2019 | 10 percent owner |
| Gunderson Thomas James | 0001708144 | May-01-2019 | director |
| Basile Edward M | 0001773661 | May-01-2019 | director |
| Provost Miriam | 0001773663 | May-01-2019 | officer: VP of US Regulatory & FDA Rel. |
| Weill David | 0001774270 | May-01-2019 | director |
| Carey John F | 0001774272 | May-01-2019 | officer: VP of Operations |
| Sullivan John F | 0001774273 | May-01-2019 | officer: VP of Quality & Engineering |
| Gordon Stephen | 0001774274 | May-01-2019 | officer: Chief Financial Officer |
| Lung Biotechnology PBC | 0001774528 | May-01-2019 | 10 percent owner |
| Riva Capital Management III, LLC | 0001775371 | May-01-2019 | 10 percent owner |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TransMedics Group, Inc.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-107497 ( Act) Size: 0 KB |
Sep-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-107493 ( Act) Size: 0 KB |
Sep-17-2024 | |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-217238 (34 Act) Size: KB |
Sep-11-2024 | 241292660 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-104046 ( Act) Size: 0 KB |
Sep-05-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-101900 ( Act) Size: 0 KB |
Aug-29-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001972362-24-001257 (33 Act) Size: 0 KB |
Aug-27-2024 | 241250200 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-100208 ( Act) Size: 0 KB |
Aug-23-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001972362-24-001206 (33 Act) Size: 0 KB |
Aug-21-2024 | 241229149 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-098574 ( Act) Size: 0 KB |
Aug-19-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-24-000706 (33 Act) Size: 0 KB |
Aug-15-2024 | 241213389 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-094809 ( Act) Size: 0 KB |
Aug-09-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-094806 ( Act) Size: 0 KB |
Aug-09-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-094079 ( Act) Size: 0 KB |
Aug-08-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-24-000667 (33 Act) Size: 0 KB |
Aug-08-2024 | 241188094 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001972362-24-001084 (33 Act) Size: 0 KB |
Aug-07-2024 | 241184202 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-005836 (33 Act) Size: 0 KB |
Aug-06-2024 | 241179357 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-091017 ( Act) Size: 0 KB |
Aug-05-2024 | |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-089316 (34 Act) Size: KB |
Aug-01-2024 | 241167022 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-24-000649 (33 Act) Size: 0 KB |
Aug-01-2024 | 241166672 |
| 8-K | Document | Current report filing Acc-no: 0000950170-24-088689 (34 Act) Size: KB |
Jul-31-2024 | 241162938 |
Recent 20 filings. View all TransMedics Group, Inc. filings
Reviews
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Catherine
Thanks I look forward to using the product to improve my skin tone
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Frequently Asked Questions
Tags:
- TransMedics Group, Inc. overview
- TransMedics Group, Inc. job
- TransMedics Group, Inc. stock
- TransMedics Group, Inc. ownership
- TransMedics Group, Inc. CEO
- TransMedics Group, Inc. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Pheton Holdings Ltd
Update: Nov 02, 2023
CardieX Ltd
Update: Jul 26, 2023
PIXIE DUST TECHNOLOGIES, INC.
Update: Jun 08, 2023
Cortigent, Inc.
Update: Mar 21, 2023
Neuraxis, INC
Update: Jan 11, 2023
ZOLL MEDICAL CORP
Update: Aug 26, 2022
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 